CBIC of Virginia honored the team with “Innovator-of-the-Year”last night June 1st for the AMPEL Genomic Platform of RNA analytics and Machine Learning for dynamic disease management through flare prediction & personalized decision support for drug options.
AMPEL is in commercialization mode & is executing on its platform technology. LuGENE, the blood test, is available this year across the United States through ReLATE. Thank you to Angel Williams Derricott for her unwavering Advocacy for Lupus & celebrating with the AMPEL team at CBIC.
Over the last year, AMPEL has announced application of our cloud platform technology to Dermatology, Fibromyalgia, Cardiology, Nephrology, Infectious Disease for our portfolio of blood & biopsy tests for precision medicine.
We have received national recognition with AMPEL’s election to Coalition for 21st Century Precision Medicine as well as interviews on Biotalk & Bloomberg Markets. Earlier this year, AMPEL was recognized with a Virginia Catalyst award and ranked by Nature in in the top five Precision Medicine Companies with respect to published science (Foundation Medicine, Illumina, Tempus, ThermoFischer, AMPEL BioSolutions, Guardant Health, AdaptiveTechnologies).
Charlottesville Business Innovation Council (CBIC) presented AMPEL’s “Innovator-of-the-Year” award at the University of Virginia Research Park, the site of AMPEL’s original office before becoming the anchor Data Science company in downtowm Charlottesville in Lewis & Clark Square.